Reuters logo
BRIEF-CymaBay Therapeutics reports Q2 loss per share $0.31
2017年8月10日 / 晚上8点15分 / 1 个月前

BRIEF-CymaBay Therapeutics reports Q2 loss per share $0.31

Aug 10 (Reuters) - CymaBay Therapeutics Inc-

* CymaBay reports second quarter 2017 financial results and provides corporate update

* Q2 loss per share $0.31

* Q2 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below